Lucero has moved its offices to AstraZeneca’s BioVentureHub in Mölndal, Sweden.
We are pleased to announce the relocation of our offices to AstraZeneca’s BioVentureHub. Lucero will continue to develop our 3D cell culture handling platform with the aim of enabling pharmaceutical companies to implement 3D cell culture at scale in their preclinical drug development.
“We truly believe that the BioVentureHub’s “dare-to-share” philosophy and collaborative approach to solving challenges is instrumental to the growth and development of the life-science sector, and we are thrilled to be a part of, and contribute to, this ecosystem.” – Christopher Jacklin, Co-founder of Lucero.
We look forward to future interactions with not only AstraZeneca, but with all of the innovative life-science companies located at the Hub.
To learn more, read the official BioVentureHub press release.
